Patient | Sex | Age(years) | Symptom duration (years) | Bladder capacity on FVC (ml) | Times of hydrodistension before HBO | Sessions of HBO treatment | Response to HBO | PBS/IC subtype based on hydrodistension | Observation duration after HBO (months) |
---|---|---|---|---|---|---|---|---|---|
1* | female | 79 | 2.2 | 40 | 2 | 20 | Responder | Ulcerative | 50 |
2* | female | 61 | 4.5 | 60 | 2 | 20 | Responder | Ulcerative | 44 |
3 | female | 28 | 1.8 | 80 | 1 | 10 | Non-responder | Non-ulcerative | 4 |
4 | female | 68 | 2.4 | 70 | 4 | 10 | Responder | Ulcerative | 33 |
5 | female | 57 | 3.6 | 80 | 4 | 10 | Responder | Ulcerative | 15 |
6 | male | 65 | 4 | 50 | 2 | 20 | Non-responder | Non-ulcerative | 30 |
7 | female | 70 | 3.2 | 100 | 1 | 10 | Responder | Ulcerative | 14 |
8 | female | 50 | 2.1 | 90 | 2 | 10 | Non-responder | Non-ulcerative | 4 |
9 | female | 70 | 6.4 | 40 | 6 | 10 | Responder | Ulcerative | 13 |
10 | female | 43 | 3.5 | 120 | 1 | 10 | Non-responder | Ulcerative | 3 |
11 | female | 70 | 3.2 | 50 | 4 | 10 | Responder | Ulcerative | 12 |